Healthcare provider profile · identity verified

Gary V Hoss, M.D.

Internal Medicine · GARLAND, TX · NPI 1083642714

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	839	248
Levothyroxine Sodium	Levothyroxine Sodium	554	164
Lisinopril	Lisinopril	481	145
Amlodipine Besylate	Amlodipine Besylate	470	145
Metformin Hcl	Metformin Hcl	423	133
Losartan Potassium	Losartan Potassium	328	106
Hydrochlorothiazide	Hydrochlorothiazide	312	97
Alprazolam	Alprazolam	299	61
Glimepiride	Glimepiride	283	84
Gabapentin	Gabapentin	265	81
Simvastatin	Simvastatin	263	78
Omeprazole	Omeprazole	262	84
Rosuvastatin Calcium	Rosuvastatin Calcium	239	73
Pantoprazole Sodium	Pantoprazole Sodium	229	73
Tamsulosin Hcl	Tamsulosin Hcl	227	67
Metoprolol Succinate	Metoprolol Succinate	226	65
Montelukast Sodium	Montelukast Sodium	222	72
Trazodone Hcl	Trazodone Hcl	222	64
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	185	40
Escitalopram Oxalate	Escitalopram Oxalate	175	47
Ozempic	Semaglutide	174	33
Tramadol Hcl	Tramadol Hcl	169	37
Sertraline Hcl	Sertraline Hcl	166	48
Pravastatin Sodium	Pravastatin Sodium	156	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	149	46
Allopurinol	Allopurinol	145	43
Jardiance	Empagliflozin	133	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	121	34
Potassium Chloride	Potassium Chloride	115	36
Prednisone	Prednisone	110	92
Zolpidem Tartrate	Zolpidem Tartrate	108	28
Fluticasone Propionate	Fluticasone Propionate	104	44
Pioglitazone Hcl	Pioglitazone Hcl	102	29
Lorazepam	Lorazepam	101	22
Albuterol Sulfate Hfa	Albuterol Sulfate	98	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	32
Carvedilol	Carvedilol	94	31
Finasteride	Finasteride	94	29
Bupropion Xl	Bupropion Hcl	91	22
Meloxicam	Meloxicam	90	34
Furosemide	Furosemide	86	34
Duloxetine Hcl	Duloxetine Hcl	84	26
Metoprolol Tartrate	Metoprolol Tartrate	84	30
Esomeprazole Magnesium	Esomeprazole Magnesium	81	22
Fluoxetine Hcl	Fluoxetine Hcl	75	23
Clopidogrel	Clopidogrel Bisulfate	74	25
Eliquis	Apixaban	74	19
Clonazepam	Clonazepam	73	16
Diazepam	Diazepam	70	15
Synthroid	Levothyroxine Sodium	68	22
Farxiga	Dapagliflozin Propanediol	62	13
Estradiol	Estradiol	60	21
Spironolactone	Spironolactone	59	18
Doxycycline Monohydrate	Doxycycline Monohydrate	54	46
Ezetimibe	Ezetimibe	54	17
Celecoxib	Celecoxib	53	13
Citalopram Hbr	Citalopram Hydrobromide	52	13
Doxazosin Mesylate	Doxazosin Mesylate	52	14
Venlafaxine Hcl Er	Venlafaxine Hcl	50	18
Tizanidine Hcl	Tizanidine Hcl	48	14
Nifedipine Er	Nifedipine	47	14
Atenolol	Atenolol	46	15
Buspirone Hcl	Buspirone Hcl	45	13
Benazepril Hcl	Benazepril Hcl	43	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	15
Oxybutynin Chloride	Oxybutynin Chloride	43	14
Hydralazine Hcl	Hydralazine Hcl	42	11
Metformin Hcl Er	Metformin Hcl	42	11
Novolog Flexpen	Insulin Aspart	42	12
Alendronate Sodium	Alendronate Sodium	40	17
Tresiba Flextouch U-100	Insulin Degludec	40	11
Januvia	Sitagliptin Phosphate	39	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	39	34
Nebivolol Hcl	Nebivolol Hcl	38	11
Olmesartan Medoxomil	Olmesartan Medoxomil	37	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	35	suppressed
Fenofibrate	Fenofibrate	35	11
Xarelto	Rivaroxaban	35	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	33	13
Methocarbamol	Methocarbamol	32	18
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	31	14
Humalog Kwikpen U-100	Insulin Lispro	31	suppressed
Ramipril	Ramipril	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Glipizide Er	Glipizide	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Nystatin	Nystatin	27	13
Warfarin Sodium	Warfarin Sodium	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Glyburide	Glyburide	26	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	25	suppressed
Ondansetron Odt	Ondansetron	25	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	15
Cefuroxime	Cefuroxime Axetil	22	17
Cephalexin	Cephalexin	22	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Testosterone	Testosterone	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Famotidine	Famotidine	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Fluconazole	Fluconazole	19	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Naproxen	Naproxen	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Azithromycin	Azithromycin	18	17
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	18	suppressed
Indapamide	Indapamide	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Temazepam	Temazepam	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Dutasteride	Dutasteride	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	11
Mounjaro	Tirzepatide	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Valsartan	Valsartan	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Linzess	Linaclotide	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Digoxin	Digoxin	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Topiramate	Topiramate	15	suppressed
Methylprednisolone	Methylprednisolone	14	13
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Verapamil Hcl	Verapamil Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Fosinopril Sodium	Fosinopril Sodium	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error